Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Evaluation of Capecitabine and Metabolite Pharmacokinetics in Elderly Breast and Colorectal Cancer Patients and Their Association With Toxicity and Molecular Markers of Enzyme Activity and Aging

NCT03465202 is registered in ClinicalTrials.gov with Newcastle-upon-Tyne Hospitals NHS Trust as lead sponsor.

NCT NCT03465202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03465202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Evaluation of Capecitabine and Metabolite Pharmacokinetics in Elderly Breast and Colorectal Cancer Patients and Their Association With Toxicity and Molecular Markers of Enzyme Activity and Aging
Lead sponsor
Newcastle-upon-Tyne Hospitals NHS Trust
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2016
Completion date
November 30, 2019
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer